Sbi Securities Co., Ltd. Dyne Therapeutics, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3 Trillion
- Q1 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 69 shares of DYN stock, worth $816. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69
Previous 19
263.16%
Holding current value
$816
Previous $448,000
61.16%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DYN
# of Institutions
204Shares Held
98.8MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$94.9 Million31.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$87.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$87.4 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$87.3 Million0.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$75.5 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $612M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...